Joshua M Fine Cyclo Therapeutics, Inc. (CYTH) insider trading activity

CYTH Quotes by TradingView

Joshua M Fine is Chief Financial Officer of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 16,900 shares of CYTH, which is worth approximately $16,562. The most recent transaction as insider was on Mar 29, 2021, when has been sold 50 shares (Common Stock) at a price of $7.4 per share, resulting in proceeds of $370. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.9K
0% 3M change
0% 12M change
Total Value Held $16,562

Joshua M Fine Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 29 2021
BUY
Open market or private purchase
$370 $7.4 p/Share
50 Added 0.29%
16,900 Common Stock
Jan 13 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 37.24%
16,850 Common Stock
Nov 25 2020
BUY
Open market or private purchase
$1,200 $0.08 p/Share
15,000 Added 2.14%
685,000 Common Stock
Nov 23 2020
BUY
Open market or private purchase
$800 $0.08 p/Share
10,000 Added 1.47%
670,000 Common Stock
JMF

Joshua M Fine

Chief Financial Officer
Wilton, CT

Track Institutional and Insider Activities on CYTH

Follow Cyclo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTH shares.

Notify only if

Insider Trading

Get notified when an Cyclo Therapeutics, Inc. insider buys or sells CYTH shares.

Notify only if

News

Receive news related to Cyclo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYTH